Name: Medlab Clinical (MDC) Short Position History
Creator: Shorted
License: https://creativecommons.org/licenses/by/4.0/

MDC

Pharmaceuticals, Biotechnology & Life Sciences

Medlab Clinical

Short interest: 0.02%; 0.00 pp 30d; as of 31 Aug 2021
Reported shorts: 59.8K
Shares on issue: 342.176M

Price & short interest

Toggle series, zoom, and compare · ASIC daily, T+4

About Medlab Clinical

Medlab Clinical Limited focuses on the research and development of nutritional pharmaceuticals, aiming to innovate in the biotechnology and life sciences sectors. The company leverages cutting-edge technology to develop products that address unmet medical needs, positioning itself as a leader in the Australian pharmaceutical industry.

Company profile →

Medlab Clinical (ASX:MDC) has 0.02% of its shares on issue reported as short positions as of 31 Aug 2021, or about 59,797 shares. Over the past 30 days that figure has been broadly flat, and over 90 days it has been broadly flat. MDC is classified in the Pharmaceuticals, Biotechnology & Life Sciences industry. All figures come from official ASIC short position reports, published with a four trading-day (T+4) delay.